{"id":"https://openalex.org/W1998798806","doi":"https://doi.org/10.1210/jc.2014-3066","title":"Removal of Plasma Mature and Furin-Cleaved Proprotein Convertase Subtilisin/Kexin 9 by Low-Density Lipoprotein-Apheresis in Familial Hypercholesterolemia: Development and Application of a New Assay for PCSK9","display_name":"Removal of Plasma Mature and Furin-Cleaved Proprotein Convertase Subtilisin/Kexin 9 by Low-Density Lipoprotein-Apheresis in Familial Hypercholesterolemia: Development and Application of a New Assay for PCSK9","publication_year":2014,"publication_date":"2014-10-14","ids":{"openalex":"https://openalex.org/W1998798806","doi":"https://doi.org/10.1210/jc.2014-3066","mag":"1998798806","pmid":"https://pubmed.ncbi.nlm.nih.gov/25313916"},"language":"en","primary_location":{"id":"doi:10.1210/jc.2014-3066","doi":"https://doi.org/10.1210/jc.2014-3066","is_oa":false,"landing_page_url":"https://doi.org/10.1210/jc.2014-3066","pdf_url":null,"source":{"id":"https://openalex.org/S205775358","display_name":"The Journal of Clinical Endocrinology & Metabolism","issn_l":"0021-972X","issn":["0021-972X","1945-7197"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Endocrinology & Metabolism","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018548492","display_name":"Mika Hori","orcid":"https://orcid.org/0000-0002-5459-6984","observed_orcids":["https://orcid.org/0000-0002-5459-6984"]},"institutions":[{"id":"https://openalex.org/I4405286384","display_name":"National Cerebral and Cardiovascular Center Research Institute","ror":"https://ror.org/01zywn143","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210111404","https://openalex.org/I4405286384"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mika Hori","raw_affiliation_strings":["Department of Molecular Innovation in Lipidology (M.H., Y.Y., M.H-S.), National Cerebral and Cardiovascular Center Research Institute, 5-7-1 Fujishirodai, Suita, Osaka 565-8565, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Innovation in Lipidology (M.H., Y.Y., M.H-S.), National Cerebral and Cardiovascular Center Research Institute, 5-7-1 Fujishirodai, Suita, Osaka 565-8565, Japan","institution_ids":["https://openalex.org/I4405286384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111778810","display_name":"Mitsuaki Ishihara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210136772","display_name":"BML (Japan)","ror":"https://ror.org/04vr3cf25","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210136772"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mitsuaki Ishihara","raw_affiliation_strings":["Advanced Medical Technology and Development Division (M.I., T.K., H.H.), BML, Inc., 1361-1 Matoba, Kawagoe, Saitama 350-1101, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Advanced Medical Technology and Development Division (M.I., T.K., H.H.), BML, Inc., 1361-1 Matoba, Kawagoe, Saitama 350-1101, Japan","institution_ids":["https://openalex.org/I4210136772"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001455979","display_name":"Yumiko Yuasa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405286384","display_name":"National Cerebral and Cardiovascular Center Research Institute","ror":"https://ror.org/01zywn143","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210111404","https://openalex.org/I4405286384"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yumiko Yuasa","raw_affiliation_strings":["Department of Molecular Innovation in Lipidology (M.H., Y.Y., M.H-S.), National Cerebral and Cardiovascular Center Research Institute, 5-7-1 Fujishirodai, Suita, Osaka 565-8565, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Innovation in Lipidology (M.H., Y.Y., M.H-S.), National Cerebral and Cardiovascular Center Research Institute, 5-7-1 Fujishirodai, Suita, Osaka 565-8565, Japan","institution_ids":["https://openalex.org/I4405286384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055879912","display_name":"Hisashi Makino","orcid":"https://orcid.org/0000-0001-9953-3736","observed_orcids":["https://orcid.org/0000-0001-9953-3736"]},"institutions":[{"id":"https://openalex.org/I4210111404","display_name":"National Cerebral and Cardiovascular Center","ror":"https://ror.org/01v55qb38","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210111404"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hisashi Makino","raw_affiliation_strings":["Department of Endocrinology and Metabolism (H.M., T.T., I.K.), National Cerebral and Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka 565-8565, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endocrinology and Metabolism (H.M., T.T., I.K.), National Cerebral and Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka 565-8565, Japan","institution_ids":["https://openalex.org/I4210111404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110096859","display_name":"Koji Yanagi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Koji Yanagi","raw_affiliation_strings":["Department of Cardiology (K.Y.), Kenporen Osaka Central Hospital, Umeda 3-3-30, Kita-ku, Osaka 530-0001, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiology (K.Y.), Kenporen Osaka Central Hospital, Umeda 3-3-30, Kita-ku, Osaka 530-0001, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055858103","display_name":"Tamiko Tamanaha","orcid":"https://orcid.org/0009-0006-9440-1930","observed_orcids":["https://orcid.org/0009-0006-9440-1930"]},"institutions":[{"id":"https://openalex.org/I4210111404","display_name":"National Cerebral and Cardiovascular Center","ror":"https://ror.org/01v55qb38","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210111404"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tamiko Tamanaha","raw_affiliation_strings":["Department of Endocrinology and Metabolism (H.M., T.T., I.K.), National Cerebral and Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka 565-8565, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endocrinology and Metabolism (H.M., T.T., I.K.), National Cerebral and Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka 565-8565, Japan","institution_ids":["https://openalex.org/I4210111404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002254054","display_name":"Ichiro Kishimoto","orcid":"https://orcid.org/0000-0002-8322-0230","observed_orcids":["https://orcid.org/0000-0002-8322-0230"]},"institutions":[{"id":"https://openalex.org/I4210111404","display_name":"National Cerebral and Cardiovascular Center","ror":"https://ror.org/01v55qb38","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210111404"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ichiro Kishimoto","raw_affiliation_strings":["Department of Endocrinology and Metabolism (H.M., T.T., I.K.), National Cerebral and Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka 565-8565, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endocrinology and Metabolism (H.M., T.T., I.K.), National Cerebral and Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka 565-8565, Japan","institution_ids":["https://openalex.org/I4210111404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087632171","display_name":"Takeshi Kujiraoka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210136772","display_name":"BML (Japan)","ror":"https://ror.org/04vr3cf25","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210136772"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takeshi Kujiraoka","raw_affiliation_strings":["Advanced Medical Technology and Development Division (M.I., T.K., H.H.), BML, Inc., 1361-1 Matoba, Kawagoe, Saitama 350-1101, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Advanced Medical Technology and Development Division (M.I., T.K., H.H.), BML, Inc., 1361-1 Matoba, Kawagoe, Saitama 350-1101, Japan","institution_ids":["https://openalex.org/I4210136772"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106172189","display_name":"Hiroaki Hattori","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210136772","display_name":"BML (Japan)","ror":"https://ror.org/04vr3cf25","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210136772"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroaki Hattori","raw_affiliation_strings":["Advanced Medical Technology and Development Division (M.I., T.K., H.H.), BML, Inc., 1361-1 Matoba, Kawagoe, Saitama 350-1101, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Advanced Medical Technology and Development Division (M.I., T.K., H.H.), BML, Inc., 1361-1 Matoba, Kawagoe, Saitama 350-1101, Japan","institution_ids":["https://openalex.org/I4210136772"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028921297","display_name":"Mariko Harada\u2010Shiba","orcid":"https://orcid.org/0000-0002-7600-2059","observed_orcids":["https://orcid.org/0000-0002-7600-2059"]},"institutions":[{"id":"https://openalex.org/I4405286384","display_name":"National Cerebral and Cardiovascular Center Research Institute","ror":"https://ror.org/01zywn143","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210111404","https://openalex.org/I4405286384"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Mariko Harada-Shiba","raw_affiliation_strings":["Department of Molecular Innovation in Lipidology (M.H., Y.Y., M.H-S.), National Cerebral and Cardiovascular Center Research Institute, 5-7-1 Fujishirodai, Suita, Osaka 565-8565, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Innovation in Lipidology (M.H., Y.Y., M.H-S.), National Cerebral and Cardiovascular Center Research Institute, 5-7-1 Fujishirodai, Suita, Osaka 565-8565, Japan","institution_ids":["https://openalex.org/I4405286384"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5028921297"],"corresponding_institution_ids":["https://openalex.org/I4405286384"],"apc_list":{"value":3750,"currency":"USD","value_usd":3750},"apc_paid":null,"fwci":8.5809,"has_fulltext":true,"cited_by_count":58,"citation_normalized_percentile":{"value":0.98172437,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"100","issue":"1","first_page":"E41","last_page":"E49"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ldl-apheresis","display_name":"LDL apheresis","score":0.9620000123977661},{"id":"https://openalex.org/keywords/familial-hypercholesterolemia","display_name":"familial hypercholesterolemia","score":0.9860000014305115},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.48399999737739563},{"id":"https://openalex.org/keywords/apolipoprotein-b","display_name":"apolipoprotein B","score":0.9300000071525574},{"id":"https://openalex.org/keywords/ldl-cholesterol-lowering","display_name":"LDL cholesterol lowering","score":0.6190000176429749}],"concepts":[{"id":"https://openalex.org/C2780948078","wikidata":"https://www.wikidata.org/wiki/Q21130010","display_name":"PCSK9","level":5,"score":0.8885174989700317},{"id":"https://openalex.org/C2778849439","wikidata":"https://www.wikidata.org/wiki/Q6397985","display_name":"Kexin","level":5,"score":0.8286951184272766},{"id":"https://openalex.org/C2779120738","wikidata":"https://www.wikidata.org/wiki/Q2711291","display_name":"Familial hypercholesterolemia","level":3,"score":0.7708719968795776},{"id":"https://openalex.org/C2778751355","wikidata":"https://www.wikidata.org/wiki/Q1797967","display_name":"LDL apheresis","level":4,"score":0.7452102899551392},{"id":"https://openalex.org/C2778824825","wikidata":"https://www.wikidata.org/wiki/Q7250439","display_name":"Proprotein convertase","level":5,"score":0.7329192161560059},{"id":"https://openalex.org/C62746215","wikidata":"https://www.wikidata.org/wiki/Q14890615","display_name":"Apolipoprotein B","level":3,"score":0.6856502294540405},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.678425133228302},{"id":"https://openalex.org/C2777265534","wikidata":"https://www.wikidata.org/wiki/Q14916427","display_name":"Furin","level":3,"score":0.6724222302436829},{"id":"https://openalex.org/C2778114629","wikidata":"https://www.wikidata.org/wiki/Q15623825","display_name":"Evolocumab","level":5,"score":0.5212498307228088},{"id":"https://openalex.org/C2779620165","wikidata":"https://www.wikidata.org/wiki/Q28749","display_name":"Low-density lipoprotein","level":3,"score":0.5206522345542908},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.43161720037460327},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.42286211252212524},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4179789423942566},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.417934387922287},{"id":"https://openalex.org/C43554185","wikidata":"https://www.wikidata.org/wiki/Q425649","display_name":"LDL receptor","level":4,"score":0.37715819478034973},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3249119520187378},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1902013123035431},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.15871593356132507},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.12638229131698608},{"id":"https://openalex.org/C2780745583","wikidata":"https://www.wikidata.org/wiki/Q1316030","display_name":"Apolipoprotein A1","level":4,"score":0.07892665266990662}],"mesh":[{"descriptor_ui":"D000071449","descriptor_name":"Proprotein Convertase 9","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001055","descriptor_name":"Apolipoproteins B","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D001781","descriptor_name":"Blood Component Removal","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D004797","descriptor_name":"Enzyme-Linked Immunosorbent Assay","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006938","descriptor_name":"Hyperlipoproteinemia Type II","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006938","descriptor_name":"Hyperlipoproteinemia Type II","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012697","descriptor_name":"Serine Endopeptidases","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D012697","descriptor_name":"Serine Endopeptidases","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D043484","descriptor_name":"Proprotein Convertases","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D043484","descriptor_name":"Proprotein Convertases","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1210/jc.2014-3066","doi":"https://doi.org/10.1210/jc.2014-3066","is_oa":false,"landing_page_url":"https://doi.org/10.1210/jc.2014-3066","pdf_url":null,"source":{"id":"https://openalex.org/S205775358","display_name":"The Journal of Clinical Endocrinology & Metabolism","issn_l":"0021-972X","issn":["0021-972X","1945-7197"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Endocrinology & Metabolism","raw_type":"journal-article"},{"id":"pmid:25313916","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25313916","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical endocrinology and metabolism","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320316982","display_name":"National Cerebral and Cardiovascular Center","ror":"https://ror.org/01v55qb38"},{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W1483242733","https://openalex.org/W1827100336","https://openalex.org/W1976691226","https://openalex.org/W1989977571","https://openalex.org/W2004032902","https://openalex.org/W2004130102","https://openalex.org/W2019559527","https://openalex.org/W2019703802","https://openalex.org/W2026136832","https://openalex.org/W2029459374","https://openalex.org/W2040612932","https://openalex.org/W2048260373","https://openalex.org/W2056807554","https://openalex.org/W2059212845","https://openalex.org/W2065590725","https://openalex.org/W2076648603","https://openalex.org/W2083941082","https://openalex.org/W2085646712","https://openalex.org/W2089490792","https://openalex.org/W2094108957","https://openalex.org/W2094401907","https://openalex.org/W2098751189","https://openalex.org/W2099136586","https://openalex.org/W2108956796","https://openalex.org/W2110083155","https://openalex.org/W2112345742","https://openalex.org/W2122864632","https://openalex.org/W2127729207","https://openalex.org/W2128030263","https://openalex.org/W2139575534","https://openalex.org/W2146769790","https://openalex.org/W2158027965","https://openalex.org/W2158055619","https://openalex.org/W2168699093","https://openalex.org/W3209992856","https://openalex.org/W4301101845","https://openalex.org/W6607828777"],"related_works":["https://openalex.org/W2157065655","https://openalex.org/W4395039376","https://openalex.org/W2098751189","https://openalex.org/W2083941082","https://openalex.org/W2964571955","https://openalex.org/W7097338335","https://openalex.org/W2040465869","https://openalex.org/W2157115489","https://openalex.org/W3046571000","https://openalex.org/W6991852692"],"abstract_inverted_index":{"CONTEXT:":[0],"Proprotein":[1],"convertase":[2],"subtilisin/kexin":[3],"9":[4],"(PCSK9)":[5],"is":[6],"known":[7],"to":[8,13,66,96,107,249,273,282],"be":[9,290],"a":[10,50,187,241],"good":[11],"target":[12],"decrease":[14],"LDL":[15],"cholesterol":[16],"(LDL-C)":[17],"and":[18,24,37,75,80,83,90,95,126,135,175,194,225,240,258,267],"two":[19,109,145],"forms":[20,57,110,285],"of":[21,41,58,73,100,111,152,163,212,219,232,244,286,298],"PCSK9,":[22,26],"mature":[23,74,174,245,257],"furin-cleaved":[25,76,176,259],"circulate":[27],"in":[28,53,70,132,167,183,199,221,236,265],"blood.":[29],"However,":[30],"it":[31],"has":[32],"not":[33],"been":[34],"clarified":[35],"whether":[36],"how":[38],"the":[39,68,98,119,144,237],"levels":[40,122],"each":[42],"PCSK9":[43,77,121,220,246,288],"are":[44],"affected":[45],"by":[46,158,181,195,253,263,271,276],"LDL-apheresis":[47],"(LDL-A)":[48],"treatment,":[49],"standard":[51],"therapy":[52],"patients":[54],"with":[55,129,191,204,217],"severe":[56],"familial":[59],"hypercholesterolemia":[60],"(FH).":[61],"OBJECTIVE:":[62],"Our":[63],"objective":[64],"was":[65,116,148,170,247],"investigate":[67],"differences":[69],"LDL-A-induced":[71],"reduction":[72,210],"between":[78,84,143],"homozygous":[79,134,266],"heterozygous":[81,137,268],"FH,":[82],"dextran":[85],"sulfate":[86],"(DS)":[87],"cellulose":[88],"adsorption":[89],"double":[91],"membrane":[92],"(DM)":[93],"columns":[94,131],"clarify":[97],"mechanism":[99],"their":[101],"removal.":[102],"DESIGN:":[103],"A":[104,140],"sandwich":[105],"ELISA":[106,280],"measure":[108,283],"PCSK9s":[112,153,177,234,260],"using":[113],"monoclonal":[114],"antibodies":[115],"developed.":[117],"Using":[118],"ELISA,":[120],"were":[123,154,178,214,235,261],"quantified":[124],"before":[125],"after":[127,156,186,202],"LDL-A":[128,189,264],"DS":[130,192,205],"7":[133],"11":[136],"FH":[138,168,184,200,223,269],"patients.":[139],"crossover":[141],"study":[142],"column":[146],"types":[147],"performed.":[149,171],"The":[150,209,279],"profiles":[151],"analyzed":[155],"fractionation":[157],"gel":[159],"filtration":[160],"chromatography.":[161],"Immunoprecipitation":[162],"apolipoprotein":[164],"B":[165],"(apoB)":[166],"plasma":[169,233,287],"RESULTS:":[172],"Both":[173,256],"significantly":[179],"decreased":[180],"55-56%":[182],"homozygotes":[185,224],"single":[188],"treatment":[190,203],"columns,":[193],"46-48%":[196],"or":[197,206,275,295],"48-56%":[198],"heterozygotes":[201],"DM":[207],"columns.":[208],"ratios":[211],"LDL-C":[213],"strongly":[215],"correlated":[216],"that":[218],"both":[222,284],"heterozygotes.":[226],"In":[227],"addition,":[228],"more":[229],"than":[230],"80%":[231],"apoB-deficient":[238],"fraction":[239],"significant":[242],"portion":[243],"bound":[248],"apoB,":[250],"as":[251],"shown":[252],"immunoprecipitation.":[254],"CONCLUSIONS:":[255],"removed":[262],"either":[270],"binding":[272],"apoB":[274],"other":[277],"mechanisms.":[278],"method":[281],"would":[289],"useful":[291],"for":[292],"investigating":[293],"physiological":[294],"pathological":[296],"roles":[297],"PCSK9.":[299]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}